Please login to the form below

Not currently logged in
Email:
Password:

Cerenis appoints Dr John Paolini as chief medical officer

He will be responsible for the strategic planning and execution of the biopharmaceutical company's clinical trials

Dr John Paolini has joined biopharmaceutical company Cerenis as chief medical officer.

Dr Paolini comes to the Toulouse, France and Ann Arbor, US-based company with 15 years clinical and research experience, notably at Merck & Co and Bayer Healthcare Pharmaceuticals.

At Cerenis he will be responsible for the strategic planning and execution of the clinical trials for the company's portfolio of novel cardiovascular therapies, including lead product CER-001, which is currently being studied for acute coronary syndrome.

“The appointment of Dr Paolini comes at a crucial time in our development, with our lead drug candidate, CER-001 in phase II; this product addresses a significant unmet medical need and represents a multibillion dollar opportunity,” said Jean-Louis Dasseux, CEO of Cerenis.

29th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics